Literature DB >> 1763106

Individual differences in behavioral measures: correlations with nucleus accumbens dopamine measured by microdialysis.

C W Bradberry1, R J Gruen, C W Berridge, R H Roth.   

Abstract

Rats were placed in one of two novel test environments for behavioral observation. In one, exploratory behavior (assessed by hole pokes) and locomotion were assessed during a 10-min test session. In the other, the chewing of varied objects on the cage floor was rated over a 20-min session. Within 2-18 days, animals were anesthetized and microdialysis probes were implanted into the nucleus accumbens for measurement of basal and d-amphetamine-stimulated levels of dopamine (DA). These measures were then correlated with the individual behavioral rating collected earlier from the drug-free animals. We found a significant correlation between duration of exploratory behavior and amphetamine-induced DA release. Locomotor activity did not correlated with either basal or amphetamine-stimulated DA release. Duration of chewing episodes correlated with basal levels of DA, as well as with amphetamine-induced DA release. Our studies indicate that differences in the dopaminergic responsivity of the nucleus accumbens (or other circuitry influencing nucleus accumbens DA function) may contribute to individual differences in certain behaviors displayed by the animals when placed in a novel environment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1763106     DOI: 10.1016/0091-3057(91)90047-6

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  20 in total

Review 1.  Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.

Authors:  Antonio Alcaro; Robert Huber; Jaak Panksepp
Journal:  Brain Res Rev       Date:  2007-08-21

Review 2.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

3.  Selective breeding for extremes in open-field activity of mice entails a differentiation of hippocampal mossy fibers.

Authors:  Z Hausheer-Zarmakupi; D P Wolfer; M C Leisinger-Trigona; H P Lipp
Journal:  Behav Genet       Date:  1996-03       Impact factor: 2.805

4.  Individual differences in the improvement of cocaine-induced place preference response by the 5-HT2C receptor antagonist SB242084 in rats.

Authors:  Nancy Capriles; Stanley Watson; Huda Akil
Journal:  Psychopharmacology (Berl)       Date:  2011-10-12       Impact factor: 4.530

5.  Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons.

Authors:  M Marinelli; F J White
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

6.  Individual differences in behavior following amphetamine, GBR-12909, or apomorphine but not SKF-38393 or quinpirole.

Authors:  M S Hooks; D N Jones; S G Holtzman; J L Juncos; P W Kalivas; J B Justice
Journal:  Psychopharmacology (Berl)       Date:  1994-10       Impact factor: 4.530

7.  The contribution of the central nucleus of the amygdala to individual differences in amphetamine-induced hyperactivity.

Authors:  Mary E Cain; Rosemary A Coolon; Margaret J Gill
Journal:  Behav Brain Res       Date:  2009-03-19       Impact factor: 3.332

8.  Deficits of mesolimbic dopamine neurotransmission in rat dietary obesity.

Authors:  B M Geiger; M Haburcak; N M Avena; M C Moyer; B G Hoebel; E N Pothos
Journal:  Neuroscience       Date:  2009-02-11       Impact factor: 3.590

9.  Differential effects of novelty exposure on place preference conditioning to amphetamine and its oral consumption.

Authors:  Y Pelloux; J Costentin; D Duterte-Boucher
Journal:  Psychopharmacology (Berl)       Date:  2003-09-05       Impact factor: 4.530

10.  Individual differences in amphetamine self-administration: the role of the central nucleus of the amygdala.

Authors:  Mary E Cain; Emily D Denehy; Michael T Bardo
Journal:  Neuropsychopharmacology       Date:  2007-06-13       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.